Actionable news
All posts from Actionable news
Actionable news in CLLS: Cellectis SA,

Second baby gets Cellectis "designer" cells to clear leukaemia

LONDON, May 6 (Reuters) - A second baby with aggressive leukaemia has been treated in London with "designer immune cells" developed by Cellectis and, six months after treatment, she remains in remission, the French biotech firm said on Friday.

The first human use of the company's cell therapy made headlines worldwide in November when one-year-old Layla was cleared of previously incurable leukaemia at Britain's Great Ormond Street Hospital (GOSH).

Details of the latest compassionate care case, also treated at GOSH, were presented at the American Society of Gene & Cell...